Tilray Brands TLRY
NASDAQ TLRY
$4.84 +0.17 (+3.64%)
At close: Aug 21, 2026 · 4:00 PM EDT

Tilray Brands (TLRY) Net Equity Issued and Repurchased (2020 - 2026)

Tilray Brands' (TLRY) quarterly Net Equity Issued and Repurchased came in at $84.9 million in Q2 2026, up 295.88% YoY from $21.4 million in Q2 2025, and up 67.93% on a QoQ basis from $50.6 million in Q4 2025.

Tilray Brands (TLRY) Net Equity Issued and Repurchased (2020 - 2026) Analysis & Trends

Tilray Brands (TLRY) has 5 years of Net Equity Issued and Repurchased data on file, last reported at $84.9 million in Q2 2026.

  • Quarterly Net Equity Issued and Repurchased rose 295.88% year-over-year to $84.9 million in Q2 2026, while the trailing twelve-month figure through May 2026 was $158.0 million (up 3370.01% YoY) and the FY2026 annual result came in at $158.0 million, down 1.99% from the prior year.
  • Net Equity Issued and Repurchased rose to $84.9 million in Q2 2026, from $50.6 million in the prior quarter.
  • In the past five years, Net Equity Issued and Repurchased ranged from a high of $262.5 million in Q2 2022 to a low of -$121.0 million in Q2 2024.
  • A 4-year average of $60.6 million and a median of $50.6 million in 2025 frame the typical range for Net Equity Issued and Repurchased.
  • Annual changes were most pronounced in 2025 — Net Equity Issued and Repurchased sank 66.16% — and 2026, when it soared 295.88%.
  • Tracing TLRY's Net Equity Issued and Repurchased over 4 years: stood at $129.6 million in 2022, then sank by 48.71% to $66.5 million in 2024, then decreased by 23.93% to $50.6 million in 2025, then soared by 67.93% to $84.9 million in 2026.
  • The last three Net Equity Issued and Repurchased figures came in at $84.9 million (Q2 2026), $50.6 million (Q4 2025), and $22.5 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Equity Issued and Repurchased (Qtr)
1 Haleon 44.51 Bn 43.55 Bn - -
2 Teva Pharmaceutical Industries 43.52 Bn 39.86 Bn 2.15 Bn -
3 Zoetis 32.43 Bn 30.75 Bn 1.05 Bn -
4 Takeda Pharmaceutical 28.63 Bn 22.83 Bn 5.10 Bn -
5 United Therapeutics 21.87 Bn 19.21 Bn 683.80 Mn -
6 Viatris 18.98 Bn 18.09 Bn 1.46 Bn 700,000.00
7 Neurocrine Biosciences 15.43 Bn 15.04 Bn 935.80 Mn 84.80 Mn
8 Elanco Animal Health 12.02 Bn 11.49 Bn 798.00 Mn -
9 Dr Reddys Laboratories 10.14 Bn 9.98 Bn - -
10 Tilray Brands 541.05 Mn 306.41 Mn 90.52 Mn 84.92 Mn

Historic Data

Download Data
DateValue
May 31, 2026 84.92 Mn
May 31, 2026 84.92 Mn
Nov 30, 2025 50.57 Mn
Nov 30, 2025 50.57 Mn
Aug 31, 2025 22.49 Mn
Aug 31, 2025 22.49 Mn
May 31, 2025 21.45 Mn
May 31, 2025 21.45 Mn
Feb 28, 2025 28.22 Mn
Feb 28, 2025 28.22 Mn
Aug 31, 2024 66.47 Mn
Aug 31, 2024 66.47 Mn
May 31, 2024 -120.97 Mn
May 31, 2024 -120.97 Mn
Aug 31, 2022 129.59 Mn
Aug 31, 2022 129.59 Mn
May 31, 2022 262.51 Mn
May 31, 2022 262.51 Mn
Nov 30, 2020 102.82 Mn
Nov 30, 2020 102.82 Mn